PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

40,991 stories, page 417 of 684

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

P840K Unregistered Cooking Oil Seized in Pampanga: CIDG Raids San Fernando Shop Over FDA Law Violations

Daily TribuneOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

How New Phase 3 Psoriasis Data For Zasocitinib At Takeda Pharmaceutical (TSE:4502) Has Changed Its Investment Story

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Chinese biotech overtakes AI as emerging-market growth trade

The Business TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

IBRX Stock Rises Overnight: Retail Traders Hunt For Global Expansion Clues Ahead Of Biotech Conference

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

South Korea taps Korea Investment Partners to launch phase 3 trial fund - CHOSUNBIZ

ChosunbizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Korea Investment Partners Selected as Manager for Korea's First 'Phase 3 Clinical Trial Specialized Fund'

아시아경제Original source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Advisory No.2026-0809 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “Methyl Salicylate + Menthol + Camphor Natural Green Leaf Lose Pain Topical Analgesic 20g” - Food and Drug Administration

fda.gov.phOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Advisory No.2026-0805 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “OTC Natural Green Leaf Anti-Itch Cream 20g” - Food and Drug Administration

fda.gov.phOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

INTERVIEW: 'The EU’s Biotech Act is helpful, but not yet the solution,' investors say

euractiv.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

HK inno.N's K-CAB Gains Ulcer Prevention Indication, Achieving Six P-CAB Approvals in South Korea

finance.biggo.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA advisers recommend relaxing US rules on compounding peptides

ETPharma.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

HLB Pep Registers Antidiuretic Hormone API with U.S. FDA

Seoul Economic DailyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

GC Biopharma Files for Phase 2 Trial of COVID-19 mRNA Vaccine, Targets 2028 Approval

Seoul Economic DailyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Kolon TissueGene rebounds as investors bet phase 3 setback priced in - CHOSUNBIZ

ChosunbizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Chinese biotech is stealing the emerging market trade that AI dominated for two years

Startup FortuneOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

GC Green Cross Submits IND for Phase 2 Clinical Trial of COVID-19 mRNA Vaccine...Selected for Disease Control Agency Support Project

아시아경제Original source
🌍discoverynews.google.comTier 3 · Aggregated media

HK inno.N wins sixth K-CAB indication, leading South Korea’s P-CAB field - CHOSUNBIZ

ChosunbizOriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

AstraZeneca filed Form 6-K

SEC EDGAROriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

Novo Nordisk filed Form 6-K

SEC EDGAROriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

Sanofi filed Form 6-K

SEC EDGAROriginal source
🇩🇪Researchfraunhofer.deTier 2 · Direct publisher

Innovation Requires Predictability and a Reliable Policy Framework

Fraunhofer Life SciencesOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Privacy Act of 1974; Matching Program

In accordance with subsection (e)(12) of the Privacy Act of 1974, as amended, the Department of Heal...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Medicare and Medicaid Programs; Quarterly Listing of Program Issuances-April Through June 2026

This quarterly notice lists Centers for Medicare & Medicaid Services (CMS) manual instructions, subs...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Medicare Program; Approved Renewal of Deeming Authority of the National Committee for Quality Assurance (NCQA) for Medicare Advantage Health Maintenance Organizations and Preferred Provider Organizations

This notice announces our decision to approve the National Committee for Quality Assurance's renewal...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Proposed Information Collection Activity; Mental Health Assessment Form and Onsite Health Intervention Form

The Administration for Children and Families (ACF) Office of Refugee Resettlement (ORR) is requestin...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Proposed Data Collection Submitted for Public Comment and Recommendations

The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce pub...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Forms Undergoing Paperwork Reduction Act Review

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Medical Devices; General Hospital and Personal Use Devices; Classification of the Active Noise Attenuation System for Infant Incubators

The Food and Drug Administration (FDA) is classifying the active noise attenuation system for infant...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Medical Devices; Gastroenterology-Urology Devices; Classification of the Non-Medicated Topical Formulation for Treatment of Erectile Dysfunction

The Food and Drug Administration (FDA) is classifying the non- medicated topical formulation for tre...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Radioactive Drug Research Committees

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has b...

Federal RegisterOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Bupropion Hydrochloride (XL)

Official structured record identifier: 4cc3327b-92c5-4667-ae16-3e95eafcf4d8.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Ampicillin

Official structured record identifier: 4134cd79-c895-4e6e-b1d5-8e01c38bf2d1.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Topwin Speedy Enema

Official structured record identifier: 3ba8c3d2-1780-42e1-bec5-8f98771d475e.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: unspecified product

Official structured record identifier: 3a75d17a-f8f0-dbbf-e063-6394a90a370b.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: ziprasidone

Official structured record identifier: 3834670f-cc31-4ed9-87ec-b631339ae18a.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: TUMS ULTRA

Official structured record identifier: 348d3dfa-6a52-4583-96e3-83c4bf2df45b.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Lidocaine

Official structured record identifier: 27e8fdfb-e923-4f99-aff7-8b9e50228151.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Pepto Bismol

Official structured record identifier: 252b143f-eee8-f407-e063-6394a90a0a08.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Rescue Pearls

Official structured record identifier: 21f0a623-eb0c-4fb6-8970-ba51253f37f9.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Lidfix Pain Relief Patch Lidocaine

Official structured record identifier: 2149f0e3-1983-4f02-929e-ecd20357f4bb.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: ACETAMINOPHEN AND CODEINE PHOSPHATE

Official structured record identifier: 1fe39679-fd58-4d2c-ba61-49d492a2b087.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: RectoProtect

Official structured record identifier: 1ca7d6cf-85a1-41a6-a07f-cff06a7edfbb.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: aripiprazole

Official structured record identifier: 1ad7d167-1235-4c5c-8159-da8972240ede.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Pain Relief Acetaminophen PM Extra Strength

Official structured record identifier: 17d27771-a112-474f-9a58-29af0d7e1af3.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Lamotrigine

Official structured record identifier: 15d801a0-f0a5-40c1-bc88-d5ba9a02c696.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Liraglutide

Official structured record identifier: 0efc3a89-211a-4496-baab-e8265e07de2b.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Cold and Flu Severe

Official structured record identifier: 0a48f650-ad2a-4105-9ff4-2bc4d94b46d3.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: ATTITUDE Super Leaves Hand Sanitizer Orange Leaves

Official structured record identifier: 09d39169-e867-d2b1-e063-6394a90a892c.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: ATTITUDE Little Leaves Hand Sanitizer - Mango

Official structured record identifier: 09d2894d-46c0-be92-e063-6294a90aea37.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Rabeprazole sodium

Official structured record identifier: 04e88b86-e1dd-4c56-8359-45fbcc161f7d.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Pain Reliever PM Extra Strength

Official structured record identifier: 03b871e8-3e14-4ed8-a978-45129255b272.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Liquid Bandage

Official structured record identifier: 036fd504-0cda-60ab-e063-6394a90a2f18.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Metoprolol Tartrate

Official structured record identifier: 028b6e4a-1597-4d21-89d0-0bbbad21efa8.

openFDA Drug LabelsOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Effects of a Modified Injection Technique on Pain and Injection-Site Reactions to Degarelix Acetate in Patients with Advanced Prostate Cancer

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Safety and Efficacy of Oliceridine Combined with Propofol for Painless Gastroscopy: A Single-Center, Randomized, Parallel Controlled Clinical Trial.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Development and Preliminary Clinical Evaluation of a Novel Gelatin-Based Diclofenac Potassium-Medicated Lollipop for Post-adenotonsillectomy Pain Management in Children: A Prospective Pilot Study.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Risk of Neurological Adverse Events Between PD-L1 and PD-1 Inhibitors in South Korean Patients with Lung Cancer: A Target Trial Emulation Framework.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Workforce and institutional factors associated with comprehensive genomic profiling utilization in gynecologic oncology: a nationwide questionnaire survey in Japan.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

AI-integrated multi-omics platform to revolutionize anti-metastatic therapy development through circulating tumor cell profiling: SCRUM-MONSTAR-CTC.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Personalized Phage Therapy in an ICU Patient with Polymicrobial Pulmonary Infections: a case from a single-arm trial.

Europe PMCOriginal source